These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

412 related items for PubMed ID: 10577844

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The combination of melphalan, cyclophosphamide and cytosine arabinoside as a conditioning regimen for autologous bone marrow transplantation for acute leukemia.
    Wang C, Qiao Z, Yang L, Ma L, Zhang H, Zhang J.
    Chin Med J (Engl); 1996 Apr; 109(4):304-7. PubMed ID: 8758293
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Melphalan-total body irradiation and autologous bone marrow transplantation for adult acute leukemia beyond first remission.
    Mehta J, Powles R, Singhal S, Horton C, Tait D, Treleaven J.
    Bone Marrow Transplant; 1996 Jul; 18(1):119-23. PubMed ID: 8832004
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Results of intensive therapy in childhood acute myeloid leukemia, incorporating high-dose melphalan and autologous bone marrow transplantation in first complete remission.
    Tiedemann K, Waters KD, Tauro GP, Tucker D, Ekert H.
    Blood; 1993 Dec 15; 82(12):3730-8. PubMed ID: 8260710
    [Abstract] [Full Text] [Related]

  • 12. High-dose busulfan and melphalan as conditioning regimen for autologous peripheral blood progenitor cell transplantation in high-risk neuroblastoma patients.
    Molina B, Alonso L, Gonzalez-Vicent M, Andion M, Hernandez C, Lassaletta A, Cormenzana M, Lopez-Ibor B, Villa M, Molina J, Diaz MA.
    Pediatr Hematol Oncol; 2011 Mar 15; 28(2):115-23. PubMed ID: 21299340
    [Abstract] [Full Text] [Related]

  • 13. Autologous bone marrow transplantation for childhood acute lymphoblastic leukaemia in second remission - long-term follow-up.
    Vaidya SJ, Atra A, Bahl S, Pinkerton CR, Calvagna V, Horton C, Milan S, Shepherd V, Brain C, Treleaven J, Powles R, Tait D, Meller ST.
    Bone Marrow Transplant; 2000 Mar 15; 25(6):599-603. PubMed ID: 10734293
    [Abstract] [Full Text] [Related]

  • 14. High-dose vincristine, fractionated total-body irradiation and cyclophosphamide as conditioning regimen in allogeneic and autologous bone marrow transplantation for childhood acute lymphoblastic leukaemia in second remission: a 7-year Italian multicentre study.
    Uderzo C, Rondelli R, Dini G, Dallorso S, Messina C, Miniero R, Locatelli F, De Manzini A, Pession A, Balduzzi A.
    Br J Haematol; 1995 Apr 15; 89(4):790-7. PubMed ID: 7772514
    [Abstract] [Full Text] [Related]

  • 15. In vivo purging with high-dose cytarabine followed by high-dose chemoradiotherapy and reinfusion of unpurged bone marrow for adult acute myelogenous leukemia in first complete remission.
    Stein AS, O'Donnell MR, Chai A, Schmidt GM, Nademanee A, Parker PM, Smith EP, Snyder DS, Molina A, Stepan DE, Spielberger R, Somlo G, Margolin KA, Vora N, Lipsett J, Lee J, Niland J, Forman SJ.
    J Clin Oncol; 1996 Aug 15; 14(8):2206-16. PubMed ID: 8708709
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. High-dose melphalan with 6-hydroxydopamine-purged autologous bone marrow transplantation for poor-risk neuroblastoma.
    Kushner BH, Gulati SC, Kwon JH, O'Reilly RJ, Exelby PR, Cheung NK.
    Cancer; 1991 Jul 15; 68(2):242-7. PubMed ID: 1906368
    [Abstract] [Full Text] [Related]

  • 18. Long-term outcomes of myeloablation and autologous transplantation of relapsed acute myeloid leukemia in second remission: a British Society of Blood and Marrow Transplantation registry study.
    Chantry AD, Snowden JA, Craddock C, Peggs K, Roddie C, Craig JI, Orchard K, Towlson KE, Pearce RM, Marks DI, BSBMT Clinical Trials Committee.
    Biol Blood Marrow Transplant; 2006 Dec 15; 12(12):1310-7. PubMed ID: 17162213
    [Abstract] [Full Text] [Related]

  • 19. Treatment of childhood acute lymphoblastic leukemia in second remission with allogeneic bone marrow transplantation and chemotherapy: ten-year experience of the Italian Bone Marrow Transplantation Group and the Italian Pediatric Hematology Oncology Association.
    Uderzo C, Valsecchi MG, Bacigalupo A, Meloni G, Messina C, Polchi P, Di Girolamo G, Dini G, Miniero R, Locatelli F.
    J Clin Oncol; 1995 Feb 15; 13(2):352-8. PubMed ID: 7844596
    [Abstract] [Full Text] [Related]

  • 20. Intensified conditioning regimen in bone marrow transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia.
    Kröger N, Krüger W, Wacker-Backhaus G, Hegewisch-Becker S, Stockschläder M, Fuchs N, Rüssmann B, Renges H, Dürken M, Bielack S, de Wit M, Schuch G, Bartels H, Braumann D, Kuse R, Kabisch H, Erttmann R, Zander AR.
    Bone Marrow Transplant; 1998 Dec 15; 22(11):1029-33. PubMed ID: 9877263
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.